2012
DOI: 10.1016/j.actatropica.2012.08.013
|View full text |Cite
|
Sign up to set email alerts
|

Immunization with excreted/secreted proteins in AS/n mice activating cellular and humoral response against Toxoplasma gondii infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
19
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 25 publications
(21 citation statements)
references
References 47 publications
1
19
0
1
Order By: Relevance
“…The most effective approach to vaccine development to date involves live attenuated parasites (Toxovax); however, this approach is still inadequate and cannot be used in humans due to safety concerns. Likewise, although the whole parasite lysate (TLA) or excreted/secreted parasite antigens generate protective immunity that results in high protection rates [22][23][24][25], the possibility of adverse reactions in the vaccinated individuals due to undefined antigenic composition excludes these vaccines from further research as vaccines for humans. However, these examples illustrate that multi-antigenic composition has a much greater chance of generating efficient immune responses to protect from T. gondii invasion.…”
Section: Discussionmentioning
confidence: 99%
“…The most effective approach to vaccine development to date involves live attenuated parasites (Toxovax); however, this approach is still inadequate and cannot be used in humans due to safety concerns. Likewise, although the whole parasite lysate (TLA) or excreted/secreted parasite antigens generate protective immunity that results in high protection rates [22][23][24][25], the possibility of adverse reactions in the vaccinated individuals due to undefined antigenic composition excludes these vaccines from further research as vaccines for humans. However, these examples illustrate that multi-antigenic composition has a much greater chance of generating efficient immune responses to protect from T. gondii invasion.…”
Section: Discussionmentioning
confidence: 99%
“…The laboratorial diagnosis for toxoplasmosis in the 83 clinical samples was evaluated by ELISA using a tachyzoite lysate antigen (TLA) as described before [39,40]. In samples from patients with cerebral or gestational, qPCR was performed using the REP-529 molecular marker, which amplifies a highly repeatable 112 bp sequence in T. gondii genome [41].…”
Section: Laboratorial Diagnosis For Toxoplasmosismentioning
confidence: 99%
“…Each 24 hours post‐infection, tachyzoites released in supernatants were recovered, separated from the ruptured cells by centrifugation (300 g , 15 minutes) and counted in Neubauer chamber. Tachyzoites were used for: (a) EV release; (b) preparing a crude tachyzoite antigen (CTA), as previously described, and used as positive control in ELISA; (c) scanning electron microscopy analyses; and (d) RNA and miRNA extraction.…”
Section: Methodsmentioning
confidence: 99%
“…The secretion by the bradyzoite cists has been proposed as a mechanism that maintains long‐lasting immunity to the parasite . However, ESA released by tachyzoites are highly immunogenic and induce protective immunity, either antibody dependent or cell mediated . CD4+ T cells specific for ESA may be involved in the maintenance of long‐term immunity in healthy chronically infected individuals, who have low anti‐ESA antibody titers.…”
Section: Introductionmentioning
confidence: 99%